霍奇金和里德-斯特恩伯格细胞中的新分子标
Hummaira Sadaf1,2, Maciej Ambroziak1, Robert Binkowski3
1Department of Experimental Immunotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Frontiers in immunology
|June 2, 2023
概括
了解经典霍奇金淋巴瘤 (HL) 需要探索分子机制. 对分化分子30 (CD30) 集群,编程细胞死亡-1蛋白 (PD-1) 和表观遗传修饰剂的研究是新的向治疗的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 经典霍奇金淋巴瘤 (HL) 涉及霍奇金和里德-斯特恩伯格 (HRS) 细胞中的特定分子变化.
- 尽管有可用的分子数据,但目前对HL病变的理解尚不完整.
研究的目的:
- 总结关于HL发展和进展中的分子机制的当前知识.
- 对HL的现有和潜在的向疗法进行审查.
- 提出未来的研究方向,以确定新的分子标.
主要方法:
- 综述最近关于HL分子机制的发现.
- 讨论关键分子,如分化分子30 (CD30) 的集群和编程细胞死亡-1蛋白 (PD-1) 以及其配体 (PD-L1/2).
- 突出表观遗传修饰剂的作用,包括SWI/SNF和PRC2复合体.
主要成果:
- 在HL中特有的分子变化包括CD30,PD-1/PD-L1通路的失调,以及表观遗传修饰剂.
- 改变的染色体重塑复合物和表观遗传修饰剂有助于HL特异性染色体状态.
- 免疫调节途径在HL病变发生过程中至关重要.
结论:
- 对PD-1/PD-L1反向信号,染色体重塑和表观遗传学的进一步研究是必要的,以便全面了解HL.
- 通过先进的研究来确定新的分子标可以导致更有效的针对性治疗HL.
- 持续的分子研究对于推进HL治疗策略至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cytotoxic T Cells-mediated Immune Response
1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K


